Pipeline Previews

By No Comments
Lambrolizumab for Advanced Melanoma Merck has announced that the FDA has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced melanoma. Lambrolizumab is Merck’s investigational…
Read More